Health Care
COO reported Q2 FY2026 revenue growth of 7.9% to $1.08B, but swung to a net loss of $77.9M driven by a 69.5% surge in SG&A expenses that overwhelmed gross profit gains.
Key risk: SG&A Cost Escalation Risk
SG&A expenses surged 69.5% YoY to $676.2M in Q2 FY2026, converting a $184.8M operating profit into a $31.0M operating loss. If this elevated cost structure persists or worsens, profitability could remain under significant pressure for multiple quarters.
Other Health Care Supplies companies